[go: up one dir, main page]

MX9604514A - Metodo para determinar cuantitativamente colesterol. - Google Patents

Metodo para determinar cuantitativamente colesterol.

Info

Publication number
MX9604514A
MX9604514A MX9604514A MX9604514A MX9604514A MX 9604514 A MX9604514 A MX 9604514A MX 9604514 A MX9604514 A MX 9604514A MX 9604514 A MX9604514 A MX 9604514A MX 9604514 A MX9604514 A MX 9604514A
Authority
MX
Mexico
Prior art keywords
lipoprotein
cholesterol
quantitative analysis
specific
gravity
Prior art date
Application number
MX9604514A
Other languages
English (en)
Inventor
Koichi Hino
Mitsuhiro Nakamura
Mitsuhisa Manabe
Original Assignee
Daiichi Pure Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11837925&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9604514(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Pure Chemicals Co Ltd filed Critical Daiichi Pure Chemicals Co Ltd
Publication of MX9604514A publication Critical patent/MX9604514A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/962Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/824Immunological separation techniques
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/825Pretreatment for removal of interfering factors from sample
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/826Additives, e.g. buffers, diluents, preservatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165Lipid, cholesterol, or triglyceride standard or control
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497Preparation composition [e.g., lysing or precipitation, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

Un método para determinar cuantitativamente colesterol de lipoproteínas de alta densidad, caracterizado porque, antes de la determinacion de colesterol por un método enzimático, un agente tensioactivo y una substancia que forma un complejo con lipoproteínas distintas a las lipoproteínas de alta densidad se añade a una muestra que contiene lipoproteínas, el método no requiere ningun pretratamiento tal como separacion por centrífuga; con una operacion sencilla, el colesterol en HDL se puede medir de manera efectiva; también este método puede ser adaptado en una variedad de analizadores automatizados y por lo tanto es muy util en el campo de pruebas clínicas.
MX9604514A 1995-01-31 1995-04-03 Metodo para determinar cuantitativamente colesterol. MX9604514A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7013607A JP2799835B2 (ja) 1995-01-31 1995-01-31 コレステロールの定量方法
PCT/JP1995/000641 WO1996023902A1 (en) 1995-01-31 1995-04-03 Method of quantitative analysis of cholesterol

Publications (1)

Publication Number Publication Date
MX9604514A true MX9604514A (es) 1997-12-31

Family

ID=11837925

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9604514A MX9604514A (es) 1995-01-31 1995-04-03 Metodo para determinar cuantitativamente colesterol.

Country Status (16)

Country Link
US (1) US5773304A (es)
EP (1) EP0753583B1 (es)
JP (1) JP2799835B2 (es)
KR (1) KR100346658B1 (es)
CN (1) CN1072724C (es)
AT (1) ATE197070T1 (es)
AU (1) AU696681B2 (es)
CA (1) CA2185562A1 (es)
DE (1) DE69519160T2 (es)
DK (1) DK0753583T3 (es)
ES (1) ES2153030T3 (es)
GR (1) GR3035274T3 (es)
MX (1) MX9604514A (es)
PT (1) PT753583E (es)
TW (1) TW400385B (es)
WO (1) WO1996023902A1 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962340A (en) * 1994-11-02 1999-10-05 Wako Pure Chemical Industries Ltd. Homogeneous immunoassay method utilizing 5-300 mM magnesium
ES2165947T3 (es) 1995-07-21 2002-04-01 Wako Pure Chem Ind Ltd Metodo para medir la cantidad de un constituyente contenido en una lipoproteina especifica.
JP3193634B2 (ja) * 1996-05-29 2001-07-30 第一化学薬品株式会社 Ldlコレステロールの定量方法
DE69734194T2 (de) 1996-12-09 2006-06-29 Denka Seiken Co., Ltd. Verfahren zur bestimmung des cholesteringehalts von high-density-lipoproteinen
JP4428863B2 (ja) * 1998-09-18 2010-03-10 協和メデックス株式会社 リポ蛋白中のコレステロールの分別定量方法および定量用試薬
US20020188315A1 (en) * 1998-12-31 2002-12-12 Guzman Jose F. Gel tourniquet cuff
WO2000043537A1 (en) 1999-01-20 2000-07-27 Kyowa Medex Co., Ltd. Method for quantitating triglyceride in lipoprotein
JP3441993B2 (ja) 1999-01-27 2003-09-02 松下電器産業株式会社 コレステロールセンサ
ATE327514T1 (de) * 1999-03-24 2006-06-15 Daiichi Pure Chemicals Co Ltd Verfahren zur quantifizierung von cholesterin
ATE330026T1 (de) * 1999-06-21 2006-07-15 Daiichi Pure Chemicals Co Ltd Verfahren zum vorbehandeln von proben und zum quantifizieren von cholesterin in spezifischen lipoproteinen
JP3686326B2 (ja) 2000-11-08 2005-08-24 アークレイ株式会社 高密度リポタンパク質(hdl)コレステロール測定用試験片
AU2002212760A1 (en) 2000-11-14 2002-05-27 Daiichi Pure Chemicals Co., Ltd Method of lipid assay and reagent for use therein
US6898728B2 (en) * 2001-09-25 2005-05-24 Sun Microsystems, Inc. System domain targeted, configurable interconnection
CA2481851C (en) 2002-01-30 2012-04-03 Denka Seiken Co., Ltd. Method of quantifying cholesterol in high density lipoprotein and reagent compositions
WO2004035817A1 (ja) * 2002-10-16 2004-04-29 Kyowa Medex Co., Ltd. 高密度リポ蛋白中のコレステロールの測定方法および試薬
WO2004035816A1 (ja) * 2002-10-16 2004-04-29 Kyowa Medex Co., Ltd. 高密度リポ蛋白中のコレステロールの測定方法および試薬
US20050032141A1 (en) * 2003-07-17 2005-02-10 Dimagno Theodore John Dry analytical element for high-density lipoprotein cholesterol quantification
US7625721B2 (en) 2004-02-03 2009-12-01 Polymer Technology Systems, Inc. Non-precipitating bodily fluid analysis system
US7435577B2 (en) 2004-02-03 2008-10-14 Polymer Technology Systems, Inc. Direct measurement of chlolesterol from low density lipoprotein with test strip
JP4796489B2 (ja) * 2004-04-15 2011-10-19 協和メデックス株式会社 高密度リポ蛋白中のコレステロールの測定方法
US20060062690A1 (en) 2004-08-17 2006-03-23 Polymer Technology Systems, Inc. Apparatus and method of manufacturing bodily fluid test strip
MX2007001925A (es) * 2004-08-17 2007-12-12 Polymer Technology Systems Inc Sistema para analisis de fluidos corporales sin precipitacion.
EP1849876B1 (en) * 2005-02-14 2011-08-24 Kyowa Medex Co., Ltd. Method, reagent and kit for determination of cholesterol in remnant-like particles (rlp)
TWI372783B (en) * 2005-04-27 2012-09-21 Kyowa Medex Co Ltd A process for measuring the cholesterol in high density lipoprotein
CN100365409C (zh) * 2005-06-01 2008-01-30 王贤理 一种测定低密度脂蛋白胆固醇的试剂及制备方法
WO2007007392A1 (ja) 2005-07-11 2007-01-18 Wako Pure Chemical Industries, Ltd. 新規ポリマー及びこれを用いたコレステロール測定法
JP4884012B2 (ja) * 2006-01-25 2012-02-22 シスメックス株式会社 高密度リポタンパク質中コレステロール測定試薬キット及び測定方法
GB0609493D0 (en) * 2006-05-12 2006-06-21 Oxford Biosensors Ltd Cholesterol sensor
GB0609494D0 (en) * 2006-05-12 2006-06-21 Oxford Biosensors Ltd HDL cholesterol sensor using specific surfactant
US8247235B2 (en) 2007-06-08 2012-08-21 Quest Diagnostics Investments Incorporated Lipoprotein analysis by differential charged-particle mobility
CN104198690B (zh) * 2007-06-08 2016-09-07 奎斯特诊断投资公司 通过差分带电荷微粒迁移率进行脂蛋白分析
US9354200B1 (en) 2008-08-07 2016-05-31 Quest Diagnostics Investments Incorporated Detection apparatus for differential-charged particle mobility analyzer
CN102472757B (zh) * 2009-07-15 2014-12-17 松下健康医疗器械株式会社 分析用试剂
JP5813284B2 (ja) 2009-10-26 2015-11-17 デンカ生研株式会社 ApoE−containingHDL中コレステロールの測定方法
WO2012011563A1 (ja) * 2010-07-23 2012-01-26 デンカ生研株式会社 高密度リポタンパク質3中のコレステロールの定量方法
CN103080748B (zh) * 2010-07-23 2015-05-27 电化生研株式会社 高密度脂蛋白3中的胆固醇的定量方法
US9250211B2 (en) 2010-12-30 2016-02-02 Quest Diagnostics Investments Incorporated Magnetic separation of lipoproteins using dextran sulfate
US9080201B2 (en) 2011-03-16 2015-07-14 Kyowa Medex Co., Ltd. Method for measuring cholesterol in HDL subfraction, and reagents and kit therefor
CN103946711B (zh) 2011-11-11 2018-12-04 安讯希特技术有限公司 血样本的化验方法
JP6054051B2 (ja) 2012-04-11 2016-12-27 デンカ生研株式会社 高密度リポ蛋白(hdl)中のコレステロール(−c)の亜分画定量方法
EP2891718B1 (en) 2012-08-31 2019-01-30 Kyowa Medex Co., Ltd. Method for measuring cholesterol in high-density lipoprotein
WO2016024549A1 (ja) * 2014-08-12 2016-02-18 株式会社シノテスト リパーゼ活性測定用基質溶液の製造方法及び製造の簡略化方法
CN105137099A (zh) * 2015-09-08 2015-12-09 长春理工大学 一种用次血红素六肽测定血清总胆固醇方法
CN120118970A (zh) * 2023-12-08 2025-06-10 南京晶捷生物科技有限公司 总胆固醇检测复合酶液、检测试纸和检测系统

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2128670B2 (de) * 1971-06-09 1977-06-30 Merck Patent Gmbh, 6100 Darmstadt Immunologische isoenzym-bestimmungsmethode
CH582884A5 (es) * 1973-12-10 1976-12-15 Hoffmann La Roche
US4226713A (en) * 1978-04-24 1980-10-07 Goldberg Jack M Diagnostic agents
US4215993A (en) * 1978-12-04 1980-08-05 Data Medical Associates, Inc. Precipitating reagent and method for isolation and determination of high density lipoproteins in human serum
US4210557A (en) * 1978-12-15 1980-07-01 Beckman Instruments, Inc. Non-high density lipoprotein precipitant
FR2513766B1 (fr) * 1981-09-28 1985-09-13 Biomerieux Sa Procedes et reactifs de separation selective des lipoproteines de faible densite ldl et de quantification de leurs composants
US4946796A (en) * 1982-01-05 1990-08-07 International Institute Of Cellular & Molecular Pathology Method of immunoassay
DE3338836A1 (de) * 1983-10-26 1985-05-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
DE3674567D1 (de) * 1985-03-18 1990-10-31 Royal Free Hosp School Med Verbesserungen in bezug auf nachweis von viren und antikoerpern.
JPS6242110A (ja) * 1985-08-20 1987-02-24 Fujitsu Ltd 露光装置
DE3636851A1 (de) * 1986-10-29 1988-05-11 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung des cholesterins der hdl-fraktion
US5215886A (en) * 1987-06-22 1993-06-01 Patel P Jivan HDL determination in whole blood
US4900662A (en) * 1987-07-21 1990-02-13 International Immunoassay Laboratories, Inc. CK-MM myocardial infarction immunoassay
US5030555A (en) * 1988-09-12 1991-07-09 University Of Florida Membrane-strip reagent serodiagnostic apparatus and method
DE3929032C2 (de) * 1989-09-01 1998-09-03 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von HDL-Cholesterin mittels eines Schnelldiagnostikums mit integriertem Fraktionierschritt
US5403745A (en) * 1990-04-27 1995-04-04 Genzyme Corporation Determination of analytes in biological fluids in the presence of substances interfering with assays therefor
US5286626A (en) * 1991-12-13 1994-02-15 Actimed Laboratories, Inc. Process and apparatus for direct determination of low density lipoprotein
JP3107474B2 (ja) * 1993-02-17 2000-11-06 国際試薬株式会社 リポ蛋白分画中の成分の定量方法

Also Published As

Publication number Publication date
DK0753583T3 (da) 2000-11-13
EP0753583B1 (en) 2000-10-18
ES2153030T3 (es) 2001-02-16
AU2085295A (en) 1996-08-21
ATE197070T1 (de) 2000-11-15
EP0753583A1 (en) 1997-01-15
WO1996023902A1 (en) 1996-08-08
AU696681B2 (en) 1998-09-17
KR100346658B1 (ko) 2002-11-23
KR970701789A (ko) 1997-04-12
PT753583E (pt) 2001-03-30
JP2799835B2 (ja) 1998-09-21
GR3035274T3 (en) 2001-04-30
TW400385B (en) 2000-08-01
CN1072724C (zh) 2001-10-10
DE69519160T2 (de) 2001-05-17
CN1145096A (zh) 1997-03-12
EP0753583A4 (en) 1997-12-10
US5773304A (en) 1998-06-30
CA2185562A1 (en) 1996-08-08
DE69519160D1 (de) 2000-11-23
JPH08201393A (ja) 1996-08-09

Similar Documents

Publication Publication Date Title
MX9604514A (es) Metodo para determinar cuantitativamente colesterol.
US4892815A (en) Process and reagent for the specific determination of the cholesterol of the HDL fraction
DE69731203D1 (de) Methode zur quantifizierung von ldl-cholesterol
RU94038061A (ru) Способ определения гомоцистеина в пробе и набор для его осуществления
AU661414B2 (en) Improved device and method of assaying whole blood for HDL cholesterol
SU1296019A3 (ru) Способ определени липопротеинов низкой плотности в сыворотке крови
EP0887422A4 (en) METHOD FOR DETERMINING THE CHOLESTER CONTENT OF HIGH DENSITY LIPOPROTEINS
Heuck et al. Nephelometry of apolipoprotein B in human serum.
EP0250991A3 (en) Method for the specific determination of serum fructosamine content and suitable reagent mixture
MY143667A (en) Pretreatment method of samples for cholesterol quantitation, and quantitation method of cholesterol in specific lipoprotein by the use of the pretreatment method
NO963477D0 (no) Analysekuvette, fremgangsmåte samt diagnostisk sett for bestemmelse av analytter i fullblod-pröver
ATE400816T1 (de) Verfahren zum austesten biologischer probenkomponenten
Heuck et al. Simplified immunonephelometric quantitation of apolipoprotein B in hyperlipoproteinemic serum.
EP1164376A4 (en) METHOD FOR QUANTIFYING CHOLESTERIN
Fingerhut et al. Comparison of four different phenylalanine determination methods
EP0141879A1 (en) Surfactant compositions and methods for clarifying and partitioning aqueous lipid-containing specimens
Bertrand et al. Stability Duration of a Normal Control Pool for Prothrombin Time and Activated Partial Thromboplastin Time Prepared in the Hematology and Blood Bank Service of the Yaoundé University Teaching Hospital, Cameroon
WO2002006839A3 (de) Blutgruppenserologisches untersuchungsverfahren
GEP19991557B (en) Method for Determination of Lead Contents in Milk
GEP19991556B (en) Method for Determining of Copper in Milk